contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


modulight-to-publish-second-quarter-and-half-year-financial-report-on-august-22-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består primärt av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom US.

Har det skett någon större utveckling eller något värt att nämna i detta IQM och Modulight kvantberäkningssamarbete, eller är det bara ett grundläggande samarbete? Några texter har synts om ämnet.

Bra företagspresentation. Utstrålar självförtroende. Kom också ihåg 2024 års tal om kommersialisering. Sa nu att det hittills inte har funnits något att publicera.

Ny, knappt en halvtimme Modu och Orsila.https://youtu.be/tk0nQENR9DU?si=9MU7U32q6KifMSdf&t=4

Mitt tidigare inlägg i tråden för 4 år sedan. Modu designar lasrar, vilket potentiellt är en mycket lukrativ del av värdekedjan, om de kan sticka ut. Jag ser dock inga indikationer på det ännu. Vem har fått reda på vad som görs på Modus fabrik? De marknadsför sig som ”vertically integrated” men det kan väl inte stämma. Det är förmodligen montering. De kritiska instrumenten kommer väl någon annanstans ifrån. Årsredovisningen är fylld med

Jag investerade också nyligen lite i Modulight. Jag har också lagt märke till tystnaden, tydligt det tystaste företaget bland mina investeringar.

Det är tyst, tyvärr tyst. Även aktiviteten är nästan noll. Så här går åren, stora löften har förvandlats till tystnad.

Orsila har handlat 21 000 st. Ett gott tecken för mig.

Modulight

Modulight Corporation | Press Release | August 15, 2025 at 14:00:00 EESTModulight Corporation will publish its second quarter and half-year report for January–June 2025 on Friday, August 22,...

<div class="mfn-header mfn-header-finland"><p>Modulight Corporation | Press Release | August 15, 2025 at 14:00:00 EEST</p></div><div class="mfn-body"><p>Modulight Corporation will publish its second quarter and half-year report for January–June 2025 on Friday, August 22, 2025, approximately at 1:00 p.m. EEST.<br>&nbsp;<br>Modulight's CEO Seppo Orsila will present the result in an English-language webcast, which will be held on Friday, August 22, 2025, at 2:30 p.m. EEST. The broadcast can be followed at <a rel="noopener" href="https://modulight.zoom.us/webinar/register/WN_x4ovzX2ZRSGBiezz8n2-lg">https://modulight.zoom.us/webinar/register/WN_x4ovzX2ZRSGBiezz8n2-lg</a> .<br><br>Questions are to be submitted in writing in the webcast portal. CFO Anca Guina will also be present to answer questions. Presentation materials will be available before the start of the event on the company’s website at <a rel="noopener" href="https://modulight.com/reports-presentations/">https://modulight.com/reports-presentations/</a>.</p></div><div class="mfn-footer mfn-contacts mfn-94b966cad316"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>CEO Seppo Orsila m. +358 40 830 4671<br>CFO Anca Guina m. +358 40&nbsp;830 4674<br>IR Ulla Haapanen m. +358 40 830 4676<br>Email: <a rel="noopener" href="mailto:ir@modulight.com">ir@modulight.com</a></p></div><div class="mfn-footer mfn-about mfn-f80935501c1c"><p><strong class="mfn-heading-1">Modulight in brief</strong></p><hr><p>Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.</p><p>Follow&nbsp;Modulight: <a rel="noopener" href="https://modulight.com">modulight.com</a> | <a rel="noopener" href="https://twitter.com/modulight">X&nbsp;</a>|&nbsp;<a rel="noopener" href="https://www.linkedin.com/company/modulight/">LinkedIn</a> | <a rel="noopener" href="https://www.facebook.com/modulight.inc">Facebook</a>&nbsp;|&nbsp;<a rel="noopener" href="https://www.youtube.com/Modulight">YouTube</a>&nbsp;|&nbsp;<a rel="noopener" href="https://www.instagram.com/modulight.inc/">Instagram</a>&nbsp;| #killcancer #laserfamily</p></div>